Dyne Therapeutics, Inc.DYNNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank50
3Y CAGR+57.1%
5Y CAGR+27.4%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
+57.1%/yr
vs +146.7%/yr prior
5Y CAGR
+27.4%/yr
Recent acceleration
Acceleration
-89.6pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
3.4x
Strong expansion
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$1.19B+71.7%
2024$691.23M+318.7%
2023$165.08M-46.1%
2022$306.32M-28.0%
2021$425.66M+20.5%
2020$353.33M+2049.8%
2019$16.44M+98.8%
2018$8.27M-99.9%
2017$11.77B-9.8%
2016$13.05B-